BTAI•benzinga•
BioXcel Shares Are Up Today: What's Going On?
Summary
BioXcel Therapeutics, Inc. (NASDAQ: BTAI) shares are trading higher Monday following news that the U.S. Food and Drug Administration (FDA) has concluded its inspection of a site involved in the company's Phase 3 TRANQUILITY II trial.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 3, 2025 by benzinga